ELLINGTON MANAGEMENT GROUP LLC - CADENCE PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 90 filers reported holding CADENCE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 3.58 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$426,000
+255.0%
47,100
+147.9%
0.15%
+560.9%
Q3 2013$120,000–19,000–0.02%–
 Download
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q3 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders